Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB - New York Stock Exchange, Inc. - US7437131094 - Common Stock - Currency: USD

36.98  -0.63 (-1.68%)

After market: 36.98 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRLB. PRLB was compared to 128 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
In the past year PRLB had a positive cash flow from operations.
PRLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years PRLB had a positive operating cash flow.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

PRLB has a Return On Assets (2.23%) which is in line with its industry peers.
The Return On Equity of PRLB (2.48%) is worse than 62.50% of its industry peers.
The Return On Invested Capital of PRLB (2.38%) is worse than 67.97% of its industry peers.
PRLB had an Average Return On Invested Capital over the past 3 years of 2.43%. This is significantly below the industry average of 10.30%.
Industry RankSector Rank
ROA 2.23%
ROE 2.48%
ROIC 2.38%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Profit Margin of PRLB (3.31%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of PRLB has declined.
PRLB has a Operating Margin of 5.09%. This is in the lower half of the industry: PRLB underperforms 62.50% of its industry peers.
In the last couple of years the Operating Margin of PRLB has declined.
PRLB has a Gross Margin of 44.56%. This is amongst the best in the industry. PRLB outperforms 83.59% of its industry peers.
In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 5.09%
PM (TTM) 3.31%
GM 44.56%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

PRLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PRLB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PRLB has been reduced compared to 5 years ago.
The debt/assets ratio for PRLB has been reduced compared to a year ago.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.79 indicates that PRLB is not in any danger for bankruptcy at the moment.
PRLB's Altman-Z score of 8.79 is amongst the best of the industry. PRLB outperforms 92.19% of its industry peers.
The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
PRLB has a better Debt to FCF ratio (0.01) than 92.97% of its industry peers.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
PRLB has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. PRLB outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 8.79
ROIC/WACC0.24
WACC9.95%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.66 indicates that PRLB has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.66, PRLB belongs to the best of the industry, outperforming 85.16% of the companies in the same industry.
A Quick Ratio of 3.43 indicates that PRLB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.43, PRLB belongs to the best of the industry, outperforming 91.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.43
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for PRLB have decreased by -8.24% in the last year.
Measured over the past years, PRLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.19% on average per year.
PRLB shows a decrease in Revenue. In the last year, the revenue decreased by -0.59%.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%

3.2 Future

PRLB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.91% yearly.
PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.46% yearly.
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.71 indicates a rather expensive valuation of PRLB.
PRLB's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.25, PRLB is valued at the same level.
The Price/Forward Earnings ratio is 23.11, which indicates a rather expensive current valuation of PRLB.
Based on the Price/Forward Earnings ratio, PRLB is valued a bit more expensive than 60.94% of the companies in the same industry.
PRLB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 23.71
Fwd PE 23.11
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

PRLB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PRLB is cheaper than 60.16% of the companies in the same industry.
PRLB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PRLB is cheaper than 81.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.8
EV/EBITDA 12.68
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.91%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (5/30/2025, 8:27:27 PM)

After market: 36.98 0 (0%)

36.98

-0.63 (-1.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners91.01%
Inst Owner Change-0.58%
Ins Owners0.91%
Ins Owner Change1.75%
Market Cap879.01M
Analysts76.36
Price Target45.9 (24.12%)
Short Float %3.51%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.89%
Min EPS beat(2)16.42%
Max EPS beat(2)43.37%
EPS beat(4)4
Avg EPS beat(4)23.24%
Min EPS beat(4)7.67%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)30.53%
EPS beat(12)11
Avg EPS beat(12)25.76%
EPS beat(16)12
Avg EPS beat(16)20.02%
Revenue beat(2)1
Avg Revenue beat(2)0.42%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)1.46%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.46%
Revenue beat(8)4
Avg Revenue beat(8)0.63%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.04%
PT rev (1m)1.5%
PT rev (3m)1.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.71%
EPS NY rev (1m)-1.23%
EPS NY rev (3m)-1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 23.71
Fwd PE 23.11
P/S 1.75
P/FCF 12.8
P/OCF 11.29
P/B 1.31
P/tB 2.35
EV/EBITDA 12.68
EPS(TTM)1.56
EY4.22%
EPS(NY)1.6
Fwd EY4.33%
FCF(TTM)2.89
FCFY7.81%
OCF(TTM)3.27
OCFY8.85%
SpS21.07
BVpS28.19
TBVpS15.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 2.48%
ROCE 3.69%
ROIC 2.38%
ROICexc 2.8%
ROICexgc 5.63%
OM 5.09%
PM (TTM) 3.31%
GM 44.56%
FCFM 13.71%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 25.61%
Cap/Sales 1.83%
Interest Coverage 187.47
Cash Conversion 126.96%
Profit Quality 413.79%
Current Ratio 3.66
Quick Ratio 3.43
Altman-Z 8.79
F-Score7
WACC9.95%
ROIC/WACC0.24
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%
Revenue Next Year2.34%
Revenue Next 2Y3.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.98%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year53.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.04%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y6.22%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%